Cytarabine

Results: 26



#Item
1JP XVI Infrared Reference Spectra Cytarabine

JP XVI Infrared Reference Spectra Cytarabine

Add to Reading List

Source URL: jpdb.nihs.go.jp

Language: English - Date: 2016-09-20 22:48:15
    205-AUG:10 LEUK ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

    05-AUG:10 LEUK ACCRUAL REPORT - Open and Recently Closed Studies SWOG/ Support STUDY

    Add to Reading List

    Source URL: www.swogstat.org

    Language: English - Date: 2016-08-12 21:10:11
    3Indication DepoCyt® (cytarabine liposome injection) is indicated for the intrathecal treatment of lymphomatous meningitis. Important Safety Information WARNING: CHEMICAL ARACHNOIDITIS ADVERSE REACTIONS Chemical arachnoi

    Indication DepoCyt® (cytarabine liposome injection) is indicated for the intrathecal treatment of lymphomatous meningitis. Important Safety Information WARNING: CHEMICAL ARACHNOIDITIS ADVERSE REACTIONS Chemical arachnoi

    Add to Reading List

    Source URL: www.onsedge.com

    Language: English - Date: 2015-05-07 15:45:45
      4landmarks Reports from the American Society of Hematology Annual Meeting Mantle cell lymphoma HIGH-DOSE CYTARABINE (ARA-C) IMPROVES OS

      landmarks Reports from the American Society of Hematology Annual Meeting Mantle cell lymphoma HIGH-DOSE CYTARABINE (ARA-C) IMPROVES OS

      Add to Reading List

      Source URL: www.oncologyex.com

      Language: English - Date: 2013-02-19 15:44:12
        5AML Induction Protocol - Specialized

        AML Induction Protocol - Specialized

        Add to Reading List

        Source URL: txch.org

        Language: English - Date: 2014-12-17 16:45:05
        6Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann

        Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann

        Add to Reading List

        Source URL: astx.com

        Language: English
        7September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -

        September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -

        Add to Reading List

        Source URL: astx.com

        Language: English
        8FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen

        FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen

        Add to Reading List

        Source URL: astx.com

        Language: English
        9Model Dependant Optimization of formulation of Cytarabine liposomes

        Model Dependant Optimization of formulation of Cytarabine liposomes

        Add to Reading List

        Source URL: www.priory.com

        Language: English - Date: 2013-04-22 10:20:47
        10ALLG Safety and Data Monitoring Committee

        ALLG Safety and Data Monitoring Committee

        Add to Reading List

        Source URL: www.allg.org.au

        Language: English - Date: 2014-05-29 08:24:12